Thursday, July 10, 2014
Asanko and B2
Here's Asanko, formerly Keegan (apparently?):
That's a further breakout. Pretty good for a company that wants to build a mine in the middle of an Ebola epidemic, no?
Meanwhile, here's B2.
Hey, Clive? You're underperforming Ebola right now. Might wanna look into what you're doing wrong.
Yabut seriously B2 might still break out through that $2.95 resistance line, and that would make for a pop in a laggard, which is a nice thing to trade this far into a bullish junior market move.
Still, Clive has been underperforming Ebola.